MORGAN STANLEY - ENTRADA THERAPEUTICS INC ownership

ENTRADA THERAPEUTICS INC's ticker is and the CUSIP is 29384C108. A total of 34 filers reported holding ENTRADA THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 1.6%.

Quarter-by-quarter ownership
MORGAN STANLEY ownership history of ENTRADA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$330,947
-26.9%
20,946
-30.0%
0.00%
Q2 2023$452,730
-25.2%
29,903
-28.4%
0.00%
Q1 2023$605,637
+80.0%
41,768
+67.8%
0.00%
Q4 2022$336,460
+102.7%
24,886
+136.3%
0.00%
Q3 2022$166,000
-35.7%
10,530
-50.3%
0.00%
Q2 2022$258,000
+230.8%
21,185
+153.4%
0.00%
Q1 2022$78,000
+9.9%
8,361
+100.9%
0.00%
Q4 2021$71,0004,1620.00%
Other shareholders
ENTRADA THERAPEUTICS INC shareholders Q3 2022
NameSharesValueWeighting ↓
MPM ASSET MANAGEMENT LLC 4,425,784$69,750,00026.57%
5AM Venture Management, LLC 4,408,379$69,476,00013.31%
72 Investment Holdings, LLC 509,023$8,022,0006.36%
TCG Crossover Management, LLC 642,189$10,121,0003.04%
StepStone Group LP 761,277$11,998,0001.71%
Nan Fung Group Holdings Ltd 141,593$2,232,0001.42%
Redmile Group, LLC 1,954,419$30,802,0001.20%
Baker Brothers Advisors 4,865,819$76,685,0000.50%
MOORE CAPITAL MANAGEMENT, LP 105,000$1,655,0000.04%
Laurion Capital Management LP 199,066$3,137,0000.02%
View complete list of ENTRADA THERAPEUTICS INC shareholders